Generic placeholder image

Current Medicinal Chemistry

Editor-in-Chief

ISSN (Print): 0929-8673
ISSN (Online): 1875-533X

Antiviral Drugs in the Prophylaxis of HBV Infection

Author(s): A. Masgala, G. Nikolopoulos, S. Tsiodras, S. Bonovas and N. M. Sitaras

Volume 19, Issue 35, 2012

Page: [5940 - 5946] Pages: 7

DOI: 10.2174/0929867311209065940

Price: $65

conference banner
Abstract

Reactivation of hepatitis B infection (HBV) is known to occur in liver graft recipients and in chronic carriers of the surface antigen of HBV who receive immunosuppressive therapy. The use of hepatitis B immune globulin alone or in combination with antiviral agents such as lamivudine, adefovir, tenofovir, entecavir, famciclovir, ganciclovir, as prophylaxis in HBV liver transplants, has been well documented. In terms of HBV positive carriers undergoing cytotoxic chemotherapy, the preemptive use of nucleoside or nucleotide analogues seems to be effective. Monotherapy or combination of antiviral drugs, as well as the optimal duration of HBV prophylaxis, is to be determined.

Keywords: Antiviral drugs, HBV infection, immunosuppression, nucleos(t)ide analogues, prophylaxis


Rights & Permissions Print Cite
© 2024 Bentham Science Publishers | Privacy Policy